Paperonium

Antibiotic resistance · PLoS Med · 2024

Longer antibiotic use, fewer resistance genes: the summary’s p-value says convincing; its table, could be chance

1 in 100every time1 in 20the usual barabout1 in 100The summary: convincingabout1 in 5Its own Table 2: could be chance
1 in 100every time1 in 20the usual barabout1 in 100The summary:convincingabout1 in 5Its own Table 2:could be chance

How often chance alone would produce this gap if treatment length changed nothing

The paper says

The summary: gut bacteria from communities given the antibiotic azithromycin for 4.5 years, not 2.5, carried 0.80 times as many genes for resisting it. Its p-value, 0.010: with no real difference, chance alone would produce such a gap only about 1 time in 100.

Its own data show

The paper’s own Table 2 gives 0.187 for the same comparison, and its main text 0.19: about 1 time in 5, so it could easily be chance. Every other p-value the text gives for these genes matches the table. The summary’s own range, 0.50 to 1.00 times as many, reaches 1.00: no difference.

A p-value is roughly how often chance alone would produce a gap this big if there were no real difference; under 1 in 20 (0.05) usually counts as convincing. 1 in 100 passes; 1 in 5 fails. The summary’s words, “no significant increase”, fit the table. Anyone copying its number would record a convincing drop the study did not find.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR) · PLoS Med (2024) · doi:10.1371/journal.pmed.1004386